KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Cash from Operations Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -22.00%
Dec 31, 2025 -10.06%
Sep 30, 2025 22.72%
Jun 30, 2025 -2.71%
Mar 31, 2025 -13.07%
Dec 31, 2024 15.27%
Sep 30, 2024 16.95%
Jun 30, 2024 2.23%
Mar 31, 2024 15.31%
Dec 31, 2023 3.65%
Sep 30, 2023 30.01%
Jun 30, 2023 12.29%
Mar 31, 2023 20.38%
Dec 31, 2022 24.24%
Sep 30, 2022 16.57%
Jun 30, 2022 7.38%
Mar 31, 2022 34.66%
Dec 31, 2021 22.97%
Sep 30, 2021 30.26%
Jun 30, 2021 47.45%
Mar 31, 2021 79.76%
Dec 31, 2020 30.57%
Sep 30, 2020 34.04%
Jun 30, 2020 129.22%
Mar 31, 2020 44.45%
Dec 31, 2019 30.69%
Sep 30, 2019 23.13%
Jun 30, 2019 14.55%
Mar 31, 2019 17.64%
Dec 31, 2018 20.32%
Sep 30, 2018 3.97%
Jun 30, 2018 -6.89%
Mar 31, 2018 36.54%
Dec 31, 2017 5.97%
Sep 30, 2017 -17.87%
Jun 30, 2017 6.91%
Mar 31, 2017 17.34%
Dec 31, 2016 -1.65%
Sep 30, 2016 -3.73%
Jun 30, 2016 -16.68%
Mar 31, 2016 -19.86%
Dec 31, 2015 -11.13%
Sep 30, 2015 -17.64%
Jun 30, 2015 -41.64%
Mar 31, 2015 6.17%
Dec 31, 2014 -15.71%
Sep 30, 2014 -9.32%